These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3522444)

  • 1. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
    Campusano C; López JM; Campino C; Cárdenas I; Rojas A
    Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
    Agnusdei D; Zacchei F; Bigazzi S; Cepollaro C; Nardi P; Montagnani M; Gennari C
    Drugs Exp Clin Res; 1989; 15(2):97-104. PubMed ID: 2661184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcitonin, calcium lactate-gluconate + potassium phosphate, calcium phosphate: changes induced in the biology of the patient with multiple fractures].
    de Bastiani G; Nogarin L; Perusi M
    Clin Ortop; 1974; 25(4):199-204. PubMed ID: 4471239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis.
    Milhaud G; Talbot JN; Coutris G
    Biomedicine; 1975 May; 22(3):223-32. PubMed ID: 809068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S; Caubel P; Garnero P; Felsenberg D
    Maturitas; 2004 Jul; 48(3):197-207. PubMed ID: 15207885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histomorphometric and biological data on osteoporosis due to immobilization].
    Minaire P; Meunier P; Edouard C; Bernard J; Courpron P
    Rev Rhum Mal Osteoartic; 1975; 42(7-9):479-88. PubMed ID: 1179130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of elcatonin on experimental osteoporosis induced by ovariectomy and low calcium diet in beagles].
    Hori M; Takahashi H; Konno T; Inoue J; Haba T; Sakurada T; Noda T; Fujimoto K
    Nihon Yakurigaku Zasshi; 1984 Jul; 84(1):91-8. PubMed ID: 6489866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
    Miki T; Nakatsuka K; Naka H; Masaki H; Imanishi Y; Ito M; Inaba M; Morii H; Nishizawa Y
    J Bone Miner Metab; 2004; 22(6):569-76. PubMed ID: 15490267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
    Borah B; Dufresne TE; Chmielewski PA; Johnson TD; Chines A; Manhart MD
    Bone; 2004 Apr; 34(4):736-46. PubMed ID: 15050906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: a histomorphometric study.
    Alexandre C; Chappard D; Caulin F; Bertrand A; Palle S; Riffat G
    Calcif Tissue Int; 1988 Jun; 42(6):345-50. PubMed ID: 3135102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.
    Mazzuoli GF; Passeri M; Gennari C; Minisola S; Antonelli R; Valtorta C; Palummeri E; Cervellin GF; Gonnelli S; Francini G
    Calcif Tissue Int; 1986 Jan; 38(1):3-8. PubMed ID: 3079649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent acquisitions in therapy of osteoporosis of various etiologies with calcitonin].
    Vigo PL; Di Ciano L; Girardello R; Reschini E; Polli E
    Recenti Prog Med; 1977 Jun; 62(6):649-70. PubMed ID: 578332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.